Refine the list (min. 2 characters)
Keynote Presentation (In-Person)
The goal of Personalized & Precision Medicine (PPM) is to deliver optimally targeted and timed in-terventions tailored to an individual’s molecular drivers of disease. Neuropsychiatric disorders are complex conditions with multifactorial etiologies, in which genetics pl [....] » Read More
Keynote Presentation (In-Person)
Title: Neurobiology of Nicotine Addiction
Nicotine’s addiction liability is demonstrated by the high prevalence of cigarette smoking and low quit success rates, despite well-documented health risks. Even though most smokers endorse a desire to quit, very few (< 5%) actually do so in a given year without treatmen [....] » Read More
Keynote Presentation (Virtual)
Title: The antidote to dissociation is connection
As the dissociative mechanism involves a disconnection from both social interactions and aspects of internal experience. Dissociation occurs under two conditions: an overwhelming and intolerable emotional experience, and the absence of an empathetic and protective support figure. [....] » Read More
Oral Presentation (In-Person)
Background: E-cigarette use has increased substantially among young people globally, raising public health concerns about nicotine dependence and health harms. Individuals with attention-deficit/hyperactivity disorder (ADHD) may be particularly vulnerable to e-cigarette use [....] » Read More
Oral Presentation (In-Person)
Title: Palliative care ensure that life remains meaningful
Each year an estimated 56.8 million people are in need of palliative care, most of whom live in low- and middle-income countries. For children, 98% of those needing palliative care live in low- and middle-income countries with almost half of them living in Africa. Palliative care [....] » Read More
Oral Presentation (In-Person)
Title: The best treatment options for mental health recovery
Clients often seek treatment for mental health problems with little understanding of either their diagnosis or the best treatment options for addressing their concerns. Intended for clinicians from psychiatry, psychology, social work, and other regulated mental health roles, this [....] » Read More
Oral Presentation (In-Person)
Title: Dealing with addiction with happy hormones
Statement of the Problem: There is a lack of awareness about what are happy harmones and what can be done to get them. People tend to feel unhappy for multiple reasons and sort towards Addiction & Alcoholism and commit suicides in some cases. Methodology & Theoretical [....] » Read More
Oral Presentation (In-Person)
Title: The loneliness epidemic among leaders: The hidden link to addiction, burnout, and depression
In today’s high-performance corporate environment, many leaders experience profound emotional isolation despite being constantly surrounded by people. Executive loneliness has become a silent epidemic that contributes to addiction, burnout, depression, anxiety, and declinin [....] » Read More
Oral Presentation (In-Person)
Title: Self care for healing
Statement of the Problem: There is a growing lack of awareness and understanding around the importance of self-care in daily life. Many individuals neglect their own well-being due to busy schedules, societal pressures, or guilt associated with prioritizing themselves. This lack [....] » Read More
Oral Presentation (In-Person)
Biomarkers enable pre-early diagnosis, guide targeted therapy and monitor the active ty and thera-peutic responses across the diseases. Among the best-validated predictive biomarkers are autoim-munity-related ones to predict and prognosticate risks of the chronification, complica [....] » Read More
Oral Presentation (In-Person)
Title: Developments after partial legalization of cannabis in German
Cannabis used to be strictly illegal in Germany since 2017, when Cannabis has been allowed for medical reasons without specific controls, but still under controlled prescription. In April 2024 personal use of Cannabis has been allowed, with own cultivation, and “cannabis so [....] » Read More
Oral Presentation (Virtual)
Title: Beyond relapse prevention: Neuroplasticity and psychedelic-assisted therapies in addiction medicine
Addiction is increasingly understood not simply as a disorder of reward or willpower, but as a condition of maladaptive neuroplasticity in which chronic stress, trauma, and repetitive reinforcement shape rigid patterns of behavior, cognition, and emotional response. Despite advan [....] » Read More
Keynote Presentation (Virtual)
Title: Adverse childhood experiences, post-traumatic stress, and addictions
The aim of this presentation is to examine different patterns of substance use and their association with adverse childhood experiences, post-traumatic stress, and depression. Method: A cross-sectional, analytical, comparative study was conducted among a group of individuals who [....] » Read More
Oral Presentation (Virtual)
Attention-deficit/hyperactivity disorder (ADHD) is a highly prevalent neurodevelopmental disorder that often continues into adulthood, resulting in corresponding adverse social, occupational, and economic costs. Addictive behaviours, substance use disorders (SUDs), or behavioural [....] » Read More
Oral Presentation (Virtual)
Background: Eating disorders (EDs) continue to be strongly associated with underweight presentations in both public discourse and clinical practice. This weight-centered perception contributes to the underrecognition of eating disorders in individuals with normal, overweight [....] » Read More
Oral Presentation (Virtual)
Title: Trauma, addiction, mental health, and recovery
Background: Dr. Reynolds is esteemed for his extensive experience in educational leadership, mental health facilitation, substance abuse counseling, and personal as well as professional development. Abstract: Psychoeducation is a targeted therapeutic approach that teaches indi [....] » Read More
Oral Presentation (Virtual)
Background: The prevalence of UPFs in global diets has risen substantially over recent decades, and their consumption has been associated with adverse physical and mental health outcomes. Recent evidence suggests that certain processed foods exhibit addictive properties through t [....] » Read More
Oral Presentation (Virtual)
Title: Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Background: Autism spectrum disorders (ASD) are a series of neurodevelopmental disorders characterized by social disorders, rigid behaviors and narrow interests.The World Health Organization (WHO) estimates that the prevalence of ASD has been increasing over the past 50 year [....] » Read More
Oral Presentation (Virtual)
Title: “Gut microbes and mental health: Rewiring neuropsychiatric medicine through the gut–brain axis”
The gut microbiome has emerged as a pivotal regulator of brain function and mental health through the complex bidirectional network known as the gut–brain axis. Growing evidence demonstrates that intestinal microbial communities influence neurodevelopment, neurotransmission [....] » Read More
Oral Presentation (Virtual)
Major depressive disorder (MDD) is one of the leading causes of disability worldwide. Globally, an estimated 5.7% of adults suffer from depression (about 280 million people Women suffer from depression more often than men — the lifetime risk is 20-25% for women and 7-12% fo [....] » Read More
Copyright 2024 Mathews International LLC All Rights Reserved
